Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00152
|
|||||
| Drug Name |
Oleic acid
|
|||||
| Synonyms |
(Z)-Octadec-9-enoic acid; 9-Octadecenoic acid (Z)-; Century cd fatty acid; Cis-9-Octadecenoic acid; Elaidoic acid; Emersol 205; Emersol 210; Emersol 211; Emersol 213; Emersol 233LL; Emersol 6321; Extraolein 90; Glycon RO; Glycon wo; Groco 2; Groco 4; Groco 5l; Groco 6; Industrene 105; Industrene 205; Industrene 206; L'Acide oleique; Metaupon; Oelsauere; Oleine 7503; Oleinic acid; Pamolyn; Pamolyn 100; Tego-oleic 130; Vopcolene 27; Wecoline OO; Z-9-Octadecenoic acid; cis-Octadec-9-enoic acid; cis-Oleic acid; oleate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Colorectal Adenomatous Polyps [ICD11: DB35] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H34O2
|
|||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)O
|
|||||
| InChI |
InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-
|
|||||
| InChIKey |
ZQPPMHVWECSIRJ-KTKRTIGZSA-N
|
|||||
| CAS Number |
CAS 112-80-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 282.5 | Topological Polar Surface Area | 37.3 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 15 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
6.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10299740
, 10504339
, 11528277
, 11532519
, 14750979
, 17388831
, 24278605
, 24856748
, 24862437
, 24886786
, 24897936
, 24897941
, 24897944
, 24897946
, 24901337
, 24901338
, 26708080
, 26732603
, 26752911
, 26759285
, 29204451
, 3140740
, 36888286
, 3978
, 4265936
, 46391972
, 46392022
, 46392136
, 46393429
, 48185141
, 48417325
, 48423867
, 48425443
, 49854224
, 53789356
, 56311729
, 56314553
, 56365484
, 584561
, 607054
, 75221
, 7849374
, 7889573
, 7889575
, 8136926
, 8144974
, 819801
, 820852
, 823248
, 841649
|
|||||
| ChEBI ID |
CHEBI:16196
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | FATP1 | Transporter Info | Fatty acid transport protein 1 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01661764) Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | |||||
| 2 | The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport. J Neurochem. 2017 May;141(3):400-412. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.